Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384126558> ?p ?o ?g. }
- W4384126558 abstract "Pre-exposure prophylaxis (PrEP) has been available for young people for over a decade, yet only ∼15% of young people in the United States with indications for PrEP have a prescription for it. Next-generation PrEP modalities may address some of the challenges of daily oral PrEP. However, preferences for these products are unknown.From October 2020 to June 2021, we conducted an online survey of 737 cisgender, young men who have sex with men (age 15-24 years) without HIV across the United States who reported same-sex attraction or consensual sex with another man in the past 6 months. Participants completed a conjoint experiment comparing daily oral pills, event-driven oral pills, event-driven rectal douches, intramuscular injections, intravenous broadly neutralizing antibody (bnAb) infusions and subcutaneous implants. Participants ranked the products from most to least preferred. Exploded logit models examined the association between ranked preferences of PrEP modalities and socio-demographic and behavioural characteristics.Participants' mean age was 21 years (SD = 2.3), and 56% identified as White. Nineteen percent were currently taking daily oral PrEP, and another 9% had previously taken it. Participants prioritized efficacy, absence of side effects and costs in the conjoint analyses. Daily oral PrEP had the highest preference ranking, followed by event-driven oral (OR = 0.89, p = 0.058), injectable (OR = 0.83, p = 0.005), implant (OR = 0.48, p < 0.0001), bnAb infusions (OR = 0.38, p < 0.0001) and rectal douches (OR = 0.24, p < 0.0001). There were differences in PrEP preferences across age, insurance status, sexual behaviour, PrEP use history, HIV and sexually transmitted infection (STI) testing history, and STI diagnoses (omnibus tests: p < 0.05). Participants also provided reasons for selecting their top product choice: ease of use for those who chose daily oral (99%) and daily event-driven (98.5%); feel more protected against HIV for those who chose injectable (95.4%) and implants (100%); not worrying about forgetting to take it for those who chose bnAbs (93.8%); and being able to stop taking it when they want for those who chose rectal douche (90.9%).Next-generation modalities were less likely to be preferred over daily oral PrEP, with differences in the magnitude by socio-demographic and behavioural characteristics. Given the low uptake of daily oral PrEP, end-users' preferences for and concerns about PrEP products must be understood to ensure high acceptability and penetration." @default.
- W4384126558 created "2023-07-14" @default.
- W4384126558 creator A5019406212 @default.
- W4384126558 creator A5029323925 @default.
- W4384126558 creator A5035645117 @default.
- W4384126558 creator A5042623795 @default.
- W4384126558 creator A5068499035 @default.
- W4384126558 creator A5082259706 @default.
- W4384126558 creator A5089370098 @default.
- W4384126558 creator A5090749396 @default.
- W4384126558 creator A9999999999 @default.
- W4384126558 date "2023-07-01" @default.
- W4384126558 modified "2023-10-14" @default.
- W4384126558 title "Who prefers what? Correlates of preferences for next‐generation HIV prevention products among a national U.S. sample of young men who have sex with men" @default.
- W4384126558 cites W1413161224 @default.
- W4384126558 cites W1622676990 @default.
- W4384126558 cites W1972954231 @default.
- W4384126558 cites W1975595226 @default.
- W4384126558 cites W1982211810 @default.
- W4384126558 cites W1992240743 @default.
- W4384126558 cites W2009644935 @default.
- W4384126558 cites W2013125963 @default.
- W4384126558 cites W2031856125 @default.
- W4384126558 cites W2042677511 @default.
- W4384126558 cites W2063533583 @default.
- W4384126558 cites W2075423069 @default.
- W4384126558 cites W2092029460 @default.
- W4384126558 cites W2099476787 @default.
- W4384126558 cites W2101698594 @default.
- W4384126558 cites W2117633598 @default.
- W4384126558 cites W2120382102 @default.
- W4384126558 cites W2144943102 @default.
- W4384126558 cites W2150644408 @default.
- W4384126558 cites W2508961927 @default.
- W4384126558 cites W2520993191 @default.
- W4384126558 cites W2528729834 @default.
- W4384126558 cites W2595474192 @default.
- W4384126558 cites W2735098563 @default.
- W4384126558 cites W2735419956 @default.
- W4384126558 cites W2753665408 @default.
- W4384126558 cites W2754995240 @default.
- W4384126558 cites W2771585761 @default.
- W4384126558 cites W2889129922 @default.
- W4384126558 cites W2903888525 @default.
- W4384126558 cites W2939980532 @default.
- W4384126558 cites W3008946863 @default.
- W4384126558 cites W3017290780 @default.
- W4384126558 cites W3019269645 @default.
- W4384126558 cites W3022012523 @default.
- W4384126558 cites W3034495599 @default.
- W4384126558 cites W3164697337 @default.
- W4384126558 cites W3174265130 @default.
- W4384126558 cites W3180543148 @default.
- W4384126558 cites W3190424399 @default.
- W4384126558 cites W3215754521 @default.
- W4384126558 cites W4224266835 @default.
- W4384126558 cites W4224718943 @default.
- W4384126558 cites W4313593788 @default.
- W4384126558 cites W4321764466 @default.
- W4384126558 doi "https://doi.org/10.1002/jia2.26096" @default.
- W4384126558 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37439061" @default.
- W4384126558 hasPublicationYear "2023" @default.
- W4384126558 type Work @default.
- W4384126558 citedByCount "1" @default.
- W4384126558 countsByYear W43841265582023 @default.
- W4384126558 crossrefType "journal-article" @default.
- W4384126558 hasAuthorship W4384126558A5019406212 @default.
- W4384126558 hasAuthorship W4384126558A5029323925 @default.
- W4384126558 hasAuthorship W4384126558A5035645117 @default.
- W4384126558 hasAuthorship W4384126558A5042623795 @default.
- W4384126558 hasAuthorship W4384126558A5068499035 @default.
- W4384126558 hasAuthorship W4384126558A5082259706 @default.
- W4384126558 hasAuthorship W4384126558A5089370098 @default.
- W4384126558 hasAuthorship W4384126558A5090749396 @default.
- W4384126558 hasAuthorship W4384126558A9999999999 @default.
- W4384126558 hasBestOaLocation W43841265581 @default.
- W4384126558 hasConcept C118552586 @default.
- W4384126558 hasConcept C126322002 @default.
- W4384126558 hasConcept C144024400 @default.
- W4384126558 hasConcept C149923435 @default.
- W4384126558 hasConcept C150966472 @default.
- W4384126558 hasConcept C151956035 @default.
- W4384126558 hasConcept C162324750 @default.
- W4384126558 hasConcept C175444787 @default.
- W4384126558 hasConcept C205545832 @default.
- W4384126558 hasConcept C2776939746 @default.
- W4384126558 hasConcept C2776983459 @default.
- W4384126558 hasConcept C2778054375 @default.
- W4384126558 hasConcept C2779496540 @default.
- W4384126558 hasConcept C2781249084 @default.
- W4384126558 hasConcept C3013748606 @default.
- W4384126558 hasConcept C512399662 @default.
- W4384126558 hasConcept C71924100 @default.
- W4384126558 hasConcept C74909509 @default.
- W4384126558 hasConcept C81603835 @default.
- W4384126558 hasConcept C98274493 @default.
- W4384126558 hasConceptScore W4384126558C118552586 @default.
- W4384126558 hasConceptScore W4384126558C126322002 @default.
- W4384126558 hasConceptScore W4384126558C144024400 @default.
- W4384126558 hasConceptScore W4384126558C149923435 @default.